News In Brief: Sotyktu Phase III Win, Novo’s Alhemo Approval, Axsome Agitation Data, Pfizer Gives Back Sangamo Gene Therapy

Humanigen Indictment; WuXi Sells Cell And Gene Business

 
• By Mandy Jackson, Jessica Merrill, and Mary Jo Laffler
  
Novo had a hemophilia drug approval, while Pfizer gave back rights to a hemophilia A gene therapy (Shutterstock)

More from Business

More from Therapy Areas